Here are relevant reports on : hpv-diagnostic-market
-
U.S. Cervical Cancer Screening Market by Test Type (PAP, HPV), Kit Type (PAP, HPV), End User (Hospitals, Laboratories, Physicians’ Offices & Clinics) - Global Forecast to 2020
The global cervical cancer screening market was approximately $15 billion in 2014 and is estimated to grow at a CAGR of 7.0% to reach nearly $22 billion by 2020. PAP test is the largest segment of the global cervical cancer screening market. However, HPV/co-test will be the fastest-growing product segment during the forecast period.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Vaccines Market Size by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, mRNA), Type (Multivalent, Monovalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, Rotavirus, RSV, HPV, Polio), ROA (IM, SC, Oral), Competition - Global Forecast to 2031
The global vaccines market (excluding COVID-19) is projected to reach USD 71.14 billion by 2031, growing at a CAGR of 5.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Sexually Transmitted Diseases Diagnostics Market by Disease Type (CT/NG, Gonorrhea, Syphilis, Genital Herpes, Hepatitis B, HIV/AIDS, HPV), End User (Laboratory, PoC) and Geography - Global Forecast to 2027
The STDs diagnostics market size is projected to reach $99,431.6 million by 2027 from $91,441.5 million in 2022, at a CAGR of 5.6% during the forecast period. Sexually transmitted diseases diagnostics market is driven by factors such as global prevalence of HIV, CT/NG, and other STDs and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements. On the other hand, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the coming years.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostic Market by Technology (Rapid Diagnostic Test, PCR, Microscopy, ELISA, Isothermal Nucleic Acid Amplification), End User (Hospital & Diagnostic Laboratories, Blood Bank, Research Institute/Academics, Home care center) - Global Forecast to 2023
Rising prevalence of malaria in developing countries, increasing demand of molecular based diagnostics test and increasing funding and government support towards developing diagnostic kits are some of the factors driving the growth of the malaria diagnostics market. On the other hand, high expense involved in R&D activities is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, Workcell, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, HTS), End User (Pharma, Forensic, Environmental, Diagnostic Lab) - Global Forecast to 2031
The global lab automation market is projected to reach USD 8.62 billion by 2031, growing at a CAGR of 6.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Dermatology Devices Market by Type (Diagnostic (Dermatoscopes, Microscopes), Treatment (Laser, Cryotherapy), Application (Diagnostic, Medical Therapeutic, Aesthetic Therapeutic), Technology (Light), End User (Hospital) & Region - Global Forecast to 2031
The global dermatology devices market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 13.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecast to 2020
The global qPCR reagents market size is projected to grow at a CAGR of 7.7%. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
- Published: January 2016
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
